SEARCH

SEARCH BY CITATION

References

  • 1
    WHO Viral Hepatitis Prevention Board. Global surveillance and control of HCV. J Viral Hepatol 1999; 6:3548.
    Direct Link:
  • 2
    Rosen HR. Primer on hepatitis C for hospital epidemiologists. Infection Control and Hospital Epidemiology. 2000; 21:229234.MEDLINE
  • 3
    Bartenschlager R, Lohmann V. Replication of hepatitis C virus. J Gen Virol 2000; 81:16311648.MEDLINE
  • 4
    Rosen HR, Martin P. Viral hepatitis following liver transplantation. Infectious Disease Clinics of North America 2000; 14:761784.MEDLINE
  • 5
    Botarelli P, Bruenetto MR, Minutello MA, Calvo P, Unutmaz D, Weiner AJ, Choo Q-L, et al. T-lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 1993; 104:580587.MEDLINE
  • 6
    Lechmann M, Ihlenfeldt HG, Braunschweiger I, Giers G, Jung G, Matz B, Kaiser R, et al. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C virus infection and in healthy anti-hepatitis C virus-positive blood donors without viremia. Hepatology 1996; 24:790795.MEDLINE
  • 7
    Takaki A, Wiese M, Maertens G, Depal E, Seifert U, Liebetrau A, Miller JL, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nature Med 2000; 6:578689.MEDLINE
  • 8
    Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, Rumi M, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Investigation 1996; 98:706714.
  • 9
    Waldrop SL, Pitcher CJ, Peterson DM, Maino VC, Picker LJ. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J Clin Invest 1997; 99:17391750.MEDLINE
  • 10
    Rosen HR, Miner C, Wolf SL, Gretch DR. A randomized trial of daily versus b.i.d. interferon induction followed by combination rebetron therapy for HCV genotype 1 infection [Abstract]. Hepatology 1999; 30(4):192A.
  • 11
    Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, et al. Morbidity and mortality in compensated cirrhosis type C: A retrospective followup study of 384 patients. Gastroenterology 1997; 112:463472.MEDLINE
  • 12
    Tong MJ, Blatt LM, McHutchison JG, Co RL, Conrad A. Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison. Hepatology 1997; 26:16401645.MEDLINE
  • 13
    Stuyver L, Rossau R, Syseur A, Duhamel M, Vanderborght B, Van Heversaugh H, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74:10931102.MEDLINE
  • 14
    Simmonds P, Holmes EC, Cha TA, Chan SW, McOmish F, Irvine B, Beall E, et al. Classification of hepatitis C into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 1993; 74:23912397.MEDLINE
  • 15
    Fraser J, Arcus V, Kong P, Baker E, Proft T. Superantigens—powerful modifiers of the immune system. Molecular Medicine Today 2000; 6:125132.MEDLINE
  • 16
    Lewinsohn DM, Briden AL, Reed SG, Grabstein KH, Alderson MR. Mycobacterium tuberculosis-reactive CD8+ T lymphocytes: The relative contribution of classical versus nonclassical HLA restriction. J Immunol 2000; 165:925930.MEDLINE
  • 17
    Pitcher CJ, Quittner C, Peterson DM, Connors M, Koup RA, Maino VC, Picker LJ. HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nature Med 1999; 5:518525.MEDLINE
  • 18
    Liang TJ, Rehermann B, Seeff LB, Hoofnagle JH. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Annals of Internal Medicine 2000; 132:296305.MEDLINE
  • 19
    Del Prete G, De Carli M, Almerigogna F, Guidizi MG, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353357.MEDLINE
  • 20
    Fang JWS, Chow V, Lau JYN. Virology of hepatitis C virus. Clinics in Liver Disease 1997; 1:493514.
  • 21
    Gerlach JT, Diepolder HM, Jung M-C, Gruener NH, Schraut WW, Zachoval R, Hoffman R, et al. Recurrence of hepatitis C virus after loss of virus-specific CD4+ T cell response in acute hepatitis C. Gastroenterology 1999; 117:933941.MEDLINE
  • 22
    Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Ed 1998; 188:22052213.
  • 23
    Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Spyros AK, Walker BD. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997; 278:14471450.MEDLINE
  • 24
    Cramp ME, Carucci P, Rossol S, Chokshi S, Maertens G, Williams R, Naoumov NV. Hepatitis C virus specific immune responses in anti-HCV positive patients without hepatitis C viremia. Gut 1999; 44:424429.MEDLINE
  • 25
    Chang K-M, Thimme R, Melpolder JJ, Oldach D, Pemberton J, Moorhead-Loudis J, McHutchison JG, et al. Differential CD4+ and CD8+ T-cell responsiveness in hepatitis C virus infection. Hepatology 2001; 33:267276.MEDLINE
  • 26
    Dries V, von Both I, Muller M, Gerken G, Schirmacher P, Odenthal M, Bartenschlager R, et al. Detection of hepatitis C virus in paraffin-embedded liver biopsies of patients negative for viral RNA in serum. Hepatology 1999; 29:223229.MEDLINE
  • 27
    Diepolder HM, Zachoval RZ, Hoffmann RM, Wierenga EA, Santantonio T, Jung M-C, Eichenlaub D, et al. Possible mechanism involving T-lymphocyte responses to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet 1995; 346; 10061007. MEDLINE
  • 28
    Lohr HF, Gerken G, Roth M, Weyer S, Schlaak JF, Buschenfelde K-H M. The cellular immune responses induced in the followup of interferon-α treated patients with chronic hepatitis C may determine the therapy outcome. J Hepatol 1998; 29:524532.MEDLINE
  • 29
    Cooper S, Erickson AL, Adams EJ, Kansopon J, Weiner AJ, Chien DY, Houghton M, et al. Analysis of a successful immune response against hepatitis C virus. Immunity 1999; 10:439449.MEDLINE
  • 30
    Minutello MA, Pileri P, Unutmaz D, Censini S, Kuo G, Houghton M, Brunetto MR, et al. Compartmentalization of T-lymphocytes to the site of the disease: intrahepatic CD4+ T-cells specific for the protein NS4 of hepatitis C virus in patients with chronic hepatitis C. J Exp Med 1993; 178:1726.MEDLINE
  • 31
    Ferrari C, Urbani S, Penna A, Cavalli A, Valli A, Lamonaca V, Bertoni R, et al. Immunopathogenesis of hepatitis C virus infection. J Hepatology 1999; 31:3138.
  • 32
    Schirren CA, Jung M-C, Gerlach JT, Worzfeld T, Baretton G, Mamim M, Gruener H, et al. Liver-derived hepatitis C virus (HCV)-specific CD4+ T cells recognize multiple HCV epitopes and produce interferon gamma. Hepatology 2000; 32:597603.MEDLINE
  • 33
    Crispe IN, Mehal WZ. Strange brew: T cells in the liver. Immunology Today 1996; 17:522525.MEDLINE
  • 34
    Nuti S, Rosa D, Valiante NM, Saletti G, Caratozzolo M, Dellabona P, Barnaba V, et al. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis. Eur J Immunol 1998; 28:34483455.MEDLINE
  • 35
    Crispe IN. How is the liver unique? (chapter) In: T lymphocytes in the Liver: Immunobiology, Pathology, and Host Defense, edited by INCrispe. Wiley-Liss, Inc., 1999.
  • 36
    Rehermann B, Chisari FV. Cell mediated immune response to the hepatitis C virus. Curr Top Microbiol Immunol 2000; 242:299325.MEDLINE
  • 37
    Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV, Sette A. Identification of HLA-A3 and B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C. J Immunol 1999; 162:11561164.MEDLINE
  • 38
    Hiroishi K, Kita H, Kojima M, Okamoto H, Moriyama T, Kaneko T, Ishikawa T, et al. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 1997; 15:705712.